KRUSE BO (EVP, CFO, Secy & Treas.) sold 1.6% of their position (4K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $142.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2021ACC: 0001104659-21-072451
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
-4K
Net shares
Net seller
$142.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$35.61
Trade value
$142.44K
% of position
1.6%
5/24/2021
257.08K→253.08K
Total
Net shares
−4K
Net value
-$142.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2021 | S · Sale | −4K | $35.61 | $142.44K | 1.6% | 257.08K | 253.08K |
| Total | −4K | -$142.44K | ||||||
Derivative Transactions0
No derivative transactions reported